Immune responses in DAA treated chronic hepatitis C patients with and without prior RG-101 dosing

BACKGROUND & AIMS: With the introduction of DAA’s, the majority of treated chronic hepatitis C patients (CHC) achieve a viral cure. The exact mechanisms by which the virus is cleared after successful therapy, is still unknown. The aim was to assess the role of the immune system and miRNA levels...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antiviral Res
Main Authors: van der Ree, Meike H., Stelma, Femke, Willemse, Sophie B., Brown, Anthony, Swadling, Leo, van der Valk, Marc, Sinnige, Marjan J., van Nuenen, Ad C., de Vree, J. Marleen L., Klenerman, Paul, Barnes, Eleanor, Kootstra, Neeltje A., Reesink, Hendrik W.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7610787/
https://ncbi.nlm.nih.gov/pubmed/28844749
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.antiviral.2017.08.016
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados